Drug intelligence / Profile preview

ferric hydroxide polymaltose complex

Development stage
Unknown
Lead developer
Tree of Life Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Ferric hydroxide polymaltose complex (also known as iron polymaltose complex or IPC) is an oral iron supplement used for the prevention and treatment of iron deficiency and iron deficiency anemia. It consists of a stable macromolecular complex of polynuclear iron(III) hydroxide cores surrounded and stabilized by a polymaltose (partially hydrolyzed dextrin) shell. Unlike traditional ferrous salts (such as ferrous sulfate), which release free iron ions rapidly in the gastrointestinal tract and can cause significant oxidative stress and mucosal irritation, the non-ionic complex of ferric hydroxide polymaltose complex allows for controlled, active absorption of iron in the small intestine (primarily the duodenum and jejunum). This mechanism mimics physiological iron absorption, resulting in superior gastrointestinal tolerability, fewer side effects (such as constipation, nausea, and abdominal pain), and a lower risk of accidental toxicity or iron overload. Once absorbed, the iron is transported via transferrin to the bone marrow for hemoglobin synthesis or stored in the liver and spleen as ferritin.

Brand names
AmyloferCompironFeroseFerripel-3Ferripel3Ferripel 3Ferriton 3Ferriton3Ferriton-3Ferrum HausmannFerrum LekFersinolHaemojetHemaferMaltoferOrofer
Other names
ferric iron hydroxide polymaltose complexferric polymaltose complexiron hydroxide polymaltose complexiron polymaltose complexiron(III)-hydroxide polymaltose complexpolymaltose iron complexpolymaltose iron(III) complex

Beyond the preview

Go deeper on ferric hydroxide polymaltose complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ferric hydroxide polymaltose complex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call